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Lab mission:  
Metabolic rehabilitation 
 
Understand how physical activity, diet and  
pharmacology can be optimally integrated to  
reverse insulin resistance and prevent T2D 
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79 million with prediabetes=  
 
everyone in U.S. that is left-handed (30) +  
everyone who is Jewish (6) +  
all households in U.S. that own dogs (43). 
 
Insulin resistance is an underlying theme for  
Type-2 diabetes (as well as CVD)  
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Diabetes Prevention Program, NEJM, 2001 
>150’ exercise/wk. goal to lose 7% BW.  
7 Energy Metabolism Laboratory 
H 
H 
OH 
OH 
CH2OH 
H 
OH 
OH H 
Weight loss 
beneficial impact on metabolic health 
Lifestyle change 
Metformin 
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Mean weight 
loss: 3.3 kg 
 
 
Activity 
maintained at 
about 150’/wk 
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Weight loss 
beneficial impact on metabolic health 
Lifestyle change 
Metformin 
habitual activity 
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King et al., JAP, 1995 
Single dose 
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Weight  
loss 
beneficial impact on metabolic health 
Lifestyle change 
Metformin 
exercise  
training 
acute exercise 
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At sufficient dose, exercise improves metabolic  
function for a period of time but the effect 
wanes, requiring subsequent doses.  
 
Tailoring dose to achieve maximal effect is  
likely to result in biggest long-term reward    
Exercise as drug 
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What do we need to know? 
Dose:  
 Threshold (≈ 150 min/week) 
 Frequency (3+ d/wk) 
 Intensity/Duration (HIIT, sedentary time?) 
 
Interactions with diet 
 
Interactions with other medications 
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No-Exercise  
LO = 3 bouts at 50% 
VO2max,= 750 kcal  
HI = 3 bouts at 75%  
VO2max,= 750 kcal  
Braun et al. J Appl. Physiol. 1995  
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16 men 
and 
women 
Energy 
Deficit 
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Energy 
Balance 
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Interactions with diet: Energy balance? 
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DEF BAL 
Energy Ingested (kcals) 2246 ± 97 2925 ± 159 
Estimated Energy 
Expenditure (kcal) 2727 ± 182 2917 ± 169 
Energy Balance (kcal) -481 ± 24 +8 ± 20 
Weight Change (kg) -0.62 ± 0.2 +0.03 ± 0.2 
All food provided,  EE derived from RMR, 
accelerometers, food, activity records 
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90 min  
[6,6 2H] glucose  
 
60 min (20% glucose 
+ 2% [6,6 2H] glucose)  
Change 
infusate 
140 145 150 75  90 
Fasted state 
0 
Steady-state  
Whole-body and hepatic insulin action (CIG-SIT)  
Outcomes: whole-body glucose uptake and  
                    suppression of liver glucose output 
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Glucose 
Muscle 
Black et al. J Appl Physiol, 2005 
       DEF                        BAL 
19 Energy Metabolism Laboratory 
H 
H 
OH 
OH 
CH2OH 
H 
OH 
OH H 
Energy balance the only difference?  
CHO content of diets in 2 groups different.  
 
DEF = 330 g CHO/day; BAL = 410g/day. 
 
Meal (60% CHO) immediately post-exercise 
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Weight  
loss 
beneficial impact on metabolic health 
Lifestyle change Pharmacology 
exercise  
training 
acute exercise 
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Diabetes Prevention Program, NEJM, 2001 
Lifestyle + metformin = even better? 
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Exercise and metformin 
Purpose: Combined effect of metformin  
and acute exercise on insulin sensitivity and AMPK α2 
 
Hypothesis: 1 + 1 = 2 
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Overnight 
Fast 
40 min rest 
or exercise BIOPSY 90 min. stable isotope [6,6-2H] glucose  
infusion 
euglycemic 
hyperinsulinemic clamp 
Metformin group:  
pre-Met, Met + rest, post Met + Ex 
Placebo group:  
rest, exercise  
       Blood sampling Percutaneous biopsy of vastus lateralis 
 
Goodyear lab for analyses  
of  AMPK activity, glycogen, 
and western blots. 
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Sharoff et al., Am J Phys, 2010 
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Sharoff et al., Am J Phys, 2010 
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Does metformin blunt beneficial  
effects of training? 
 
32 men and women with prediabetes   
 
12 wks training with or w/o metformin,  
metformin only and control 
 
Insulin sensitivity using clamp and tracers 
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Insulin sensitivity enhanced more with exercise  
alone than when combined with metformin 
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Malin et al. Diabetes Care, 2011 
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Non glycemic outcomes 
SBP:  
C= +6.5%, M= -7.3%, EP= -6.3%, EM= 0.0% 
 
hs-CRP: 
C= +6.4%, M= -20.1%, EP= -27.4%, EM=-8.4% 
 
TAG: 
C= +3.1% M= -13.8%, EP= -13.5%, EM= -12.0% 
Malin et al. Obesity, 2012 
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Why? 
 
Wt?  Only M and E+M lost weight 
Fat?  M = nc, E+M and E+P= -2% 
Central fat? M= nc, E+M and E+P= -1.5% 
 
CRF? M = nc,  E+M ≈ +10%, E+P ≈ +20% 
 
∆VO2peak and ∆insulin sensitivity: r= .70   
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Role of “sedentary behavior” in mediating 
efficacy of the exercise drug?? 
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14 normally active men and women 
3 conditions, balanced order 
 
Active, energy bal (no sit 15 hr.) 
 
Inactive (sit 15 hr, no diet change ) 
 
Inactive, (sit 15 hr, cut kcals )  
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-39% 
-18% 
Stephens et al. Metabolism 2010 
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Kozey Keadle et al. 
Sedentary subjects 
Control, 12 wks training (EX), reduced  
sedentary time (rST) OR both (EX+rST). 
 
EX+rST accentuated impact of EX alone 
C-ISI up by 24% vs. 17.5% (but TG same) 
 
Little impact of rST alone 
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Conclusions 
At sufficient dose, exercise/physical activity 
potent countermeasure 
 
Less sedentary behavior useful but not sufficient 
 
Interxns between exercise and nutritional context 
 
Interactions with other meds NOT predictable 
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beneficial impact on metabolic health 
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